查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1968677

CT及MRI造影剂市场分析及预测（至2035年）：类型、产品类型、应用、技术、最终用户、剂型、材质类型、功能、组件、设备

CT And MRI Contrast Agents Market Analysis and Forecast to 2035: Type, Product, Application, Technology, End User, Form, Material Type, Functionality, Component, Equipment
出版日期: | 出版商: Global Insight Services | 英文 482 Pages | 商品交期: 3-5个工作天内

价格
简介目录

CT和MRI造影剂市场预计将从2024年的83.9亿美元成长到2034年的158.5亿美元，复合年增长率约为6.6%。 CT和MRI造影剂市场涵盖用于增强电脑断层扫描（CT）和磁振造影（MRI）中体内结构清晰度和可见度的物质。这些造影剂在诊断影像中至关重要，能够提高组织和血管结构的区分度。推动市场成长的因素包括慢性疾病的增加、影像技术的进步以及对早期准确诊断日益增长的需求。造影剂成分和给药方法的创新以及造影核准对于塑造市场动态和扩张至关重要。

受影像技术进步和诊断程序增加的推动，CT和MRI造影剂市场预计将迎来显着成长。就产品细分而言，碘基造影剂因其在CT影像中的广泛应用而占据主导地位。钆基造影剂因其在MRI检查中的有效性而占据第二大市场。就应用领域而言，神经影像学引领市场，这主要得益于神经系统疾病的日益增加。心血管影像学紧随其后，这主要归因于心血管疾病发生率的上升以及对精准诊断的需求。医院是主要的终端用户，这得益于其全面的诊断能力和先进成像设备的普及。诊断影像中心是第二大收入来源，它们提供快速出具结果的专业影像服务。微气泡造影技术的进步正在提高成像的准确性并拓展应用范围，从而带来新的机会。对病人安全和法规遵从性的关注仍然至关重要，这影响着产品开发和市场策略。

市场区隔
种类 碘基造影剂、钆基造影剂、微气泡造影剂
产品 口服造影、静脉注射造影、直肠造影
目的 心臟病学、神经病学、肿瘤学、消化病学、肾臟病学
科技 电脑断层扫描（CT）、磁振造影（MRI）
最终用户 医院、影像诊断中心及门诊手术中心
形式 液体、粉末
材料类型 有机物、无机物
功能 用于诊断和治疗
成分 活性药物成分和添加剂
装置 CT扫描仪， 核磁共振造影系统

市场概况：

CT和MRI造影剂市场以产品种类繁多和价格竞争激烈为特征。现有企业持续保持主导地位，而新参与企业不断推出创新产品，活性化市场动态。价格战持续进行，各公司专注于以价值为导向的提案来扩大市场占有率。先进的造影剂不断涌现，有望提高诊断准确性和病人安全性。这些发展对于维持产业发展动能和满足医疗专业人员不断变化的需求至关重要。市场竞争异常激烈，主要企业透过策略联盟和收购争夺市场领导地位。区域法规结构对市场动态重大影响，严格的合规要求塑造了产品开发和核准流程。北美市场依然强劲，这得益于技术进步和有利的报销政策。同时，由于医疗保健投资的增加，亚太地区正在经历快速成长。总体而言，在对精准诊断影像需求不断增长和造影剂技术创新的推动下，市场呈现扩张迹象。

主要趋势和驱动因素：

由于影像技术的进步和慢性病发病率的上升，CT和MRI造影剂市场正经历强劲成长。主要趋势包括新型造影剂的研发，这些造影剂能够提高影像品质和诊断准确性。这些创新使得疾病的检测和表征更加精准，有助于改善患者的治疗效果。老年人口的成长（他们罹患慢性病的风险更高）进一步推动了对先进影像解决方案的需求。此外，向非侵入性诊断技术的转变也促进了造影剂的应用。医疗机构越来越重视病人的安全和舒适度，优先考虑微创成像方式。监管部门的核准和有利的报销政策也在市场扩张中发挥关键作用。新兴地区医疗基础设施的快速发展带来了新的机会。专注于提供经济高效造影剂解决方案的公司有望占据显着的市场份额。此外，策略联盟和伙伴关係正在促进创新产品的开发，并推动市场成长。随着全球医疗系统努力提升诊断能力，CT和MRI造影剂市场预计将持续扩张。

限制与挑战：

CT和MRI造影剂市场面临许多重大限制和挑战。主要阻碍因素是严格的监管要求，这延长了核准流程并增加了生产成本。此外，造影剂的高成本限制了其可近性，尤其是在医疗预算有限的新兴市场。潜在的副作用和过敏反应等安全隐患也使市场格局更加复杂，需要严格的测试和监测。此外，超音波和先进的非造影MRI技术等无需造影剂的替代成像方式的日益普及也对市场构成挑战。同时，对个人化医疗的日益重视推动了对患者特异性造影剂的需求，增加了生产的复杂性和研发成本。这些因素共同构成了重大障碍，影响着市场的成长轨迹和可近性。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 碘造影剂
    • 钆基造影剂
    • 微气泡造影剂
  • 市场规模及预测：依产品划分
    • 口服造影
    • 静脉造影显影剂
    • 直肠造影剂
  • 市场规模及预测：依应用领域划分
    • 心臟病学
    • 神经病学
    • 肿瘤学
    • 胃肠内视镜检查
    • 肾臟病学
  • 市场规模及预测：依技术划分
    • 电脑断层扫描（CT）
    • 磁振造影（MRI）
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊断影像中心
    • 门诊手术中心
  • 市场规模及预测：依类型
    • 液体
    • 粉末
  • 市场规模及预测：依材料类型划分
    • 有机的
    • 无机物
  • 市场规模及预测：依功能划分
    • 诊断
    • 治疗
  • 市场规模及预测：依组件划分
    • 原料药
    • 添加剂
  • 市场规模及预测：依设备划分
    • CT扫描仪
    • 核磁共振造影系统

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Bracco Imaging
  • Guerbet
  • Lantheus Medical Imaging
  • Daiichi Sankyo
  • JB Chemicals and Pharmaceuticals
  • Unijules Life Sciences
  • Taejoon Pharm
  • Jodas Expoim
  • Sanochemia Pharmazeutika
  • Spago Nanomedical
  • CMR Naviscan
  • YMBioSciences
  • iMax Diagnostic Imaging
  • Beekley Medical
  • Trivitron Healthcare
  • Magnus Life
  • NantPharma
  • Aspen Pharmacare
  • Ekomed

第九章：关于我们

简介目录
Product Code: GIS33084

CT And MRI Contrast Agents Market is anticipated to expand from $8.39 billion in 2024 to $15.85 billion by 2034, growing at a CAGR of approximately 6.6%. The CT and MRI Contrast Agents Market encompasses substances used to enhance the clarity and visibility of internal body structures in computed tomography (CT) and magnetic resonance imaging (MRI) scans. These agents, crucial in diagnostic imaging, improve the differentiation of tissues and vascular structures. The market is driven by increasing prevalence of chronic diseases, advancements in imaging technologies, and rising demand for early and accurate diagnosis. Innovations in agent composition and delivery, alongside regulatory approvals, are pivotal in shaping market dynamics and expansion.

The CT and MRI Contrast Agents Market is poised for significant growth, spurred by advancements in imaging technologies and rising diagnostic procedures. In the product segment, iodinated contrast agents are leading, attributed to their widespread use in CT imaging. Gadolinium-based agents are the second highest performers, driven by their efficacy in MRI procedures. Among applications, neurological imaging holds the top position, benefiting from the increasing prevalence of neurological disorders. Cardiovascular imaging follows closely, supported by the rising incidence of cardiovascular diseases and the need for accurate diagnosis. The hospital segment is the primary end-user, given its comprehensive diagnostic capabilities and access to advanced imaging equipment. Diagnostic imaging centers are the second most lucrative, as they offer specialized imaging services with quicker turnaround times. Technological advancements, such as the development of microbubble contrast agents, present new opportunities, enhancing imaging precision and expanding application areas. The focus on patient safety and regulatory compliance remains paramount, influencing product development and market strategies.

Market Segmentation
TypeIodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media
ProductOral Contrast Agents, Intravenous Contrast Agents, Rectal Contrast Agents
ApplicationCardiology, Neurology, Oncology, Gastroenterology, Nephrology
TechnologyComputed Tomography (CT), Magnetic Resonance Imaging (MRI)
End UserHospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers
FormLiquid, Powder
Material TypeOrganic, Inorganic
FunctionalityDiagnostic, Therapeutic
ComponentActive Pharmaceutical Ingredients, Excipients
EquipmentCT Scanners, MRI Machines

Market Snapshot:

The CT and MRI contrast agents market is characterized by a diverse array of products and competitive pricing strategies. Established players continue to dominate, yet new entrants are launching innovative products, intensifying market dynamics. Pricing remains competitive, with companies focusing on value-driven propositions to enhance their market share. The market sees a steady introduction of advanced contrast agents, which promise improved diagnostic accuracy and patient safety. These developments are crucial in maintaining the industry's momentum and addressing the evolving needs of healthcare professionals. Competition is fierce, with major firms vying for market leadership through strategic partnerships and acquisitions. Regulatory frameworks across regions significantly influence market dynamics, with stringent compliance requirements shaping product development and approval processes. The North American market is robust, driven by technological advancements and favorable reimbursement policies. Meanwhile, the Asia-Pacific region is witnessing rapid growth due to increasing healthcare investments. Overall, the market is poised for expansion, fueled by rising demand for precise diagnostic imaging and innovations in contrast agent technologies.

Geographical Overview:

The CT and MRI contrast agents market is witnessing notable growth across diverse regions, each exhibiting unique characteristics. North America remains a dominant force, propelled by advanced healthcare infrastructure and increasing demand for diagnostic imaging. The presence of key players and ongoing research initiatives further bolster the market's expansion. Europe follows as a significant contributor, with rising healthcare expenditures and a growing elderly population driving the demand for contrast agents. Asia Pacific emerges as a promising growth pocket, fueled by rapid urbanization and an expanding middle class seeking improved healthcare services. China and India are at the forefront, with substantial investments in healthcare infrastructure and technology adoption. Latin America and the Middle East & Africa are gaining traction as emerging markets. In Latin America, improving healthcare facilities and a focus on enhancing diagnostic capabilities are key growth drivers. Meanwhile, the Middle East & Africa are witnessing increased investments in healthcare to support economic development and innovation.

Key Trends and Drivers:

The CT and MRI contrast agents market is experiencing robust growth driven by technological advancements in imaging techniques and increasing prevalence of chronic diseases. Key trends include the development of novel contrast agents that enhance image quality and diagnostic accuracy. These innovations are enabling more precise detection and characterization of medical conditions, thereby improving patient outcomes. The growing geriatric population, with its higher susceptibility to chronic diseases, is further fueling demand for advanced imaging solutions. Additionally, the shift towards non-invasive diagnostic procedures is propelling the adoption of contrast agents. Healthcare providers are increasingly prioritizing patient safety and comfort, leading to a preference for imaging modalities that minimize invasiveness. Regulatory approvals and favorable reimbursement policies are also playing a pivotal role in market expansion. Opportunities are emerging in developing regions where healthcare infrastructure is rapidly advancing. Companies focusing on affordable and effective contrast solutions are poised to capture significant market share. Furthermore, strategic collaborations and partnerships are facilitating the development of innovative products, thus driving market growth. As healthcare systems worldwide strive for improved diagnostic capabilities, the CT and MRI contrast agents market is set to witness sustained expansion.

Restraints and Challenges:

The CT and MRI contrast agents market encounters several significant restraints and challenges. A primary restraint is the stringent regulatory requirements, which prolong approval processes and increase costs for manufacturers. Additionally, the high cost of contrast agents limits accessibility, especially in emerging markets with constrained healthcare budgets. Safety concerns regarding potential side effects and allergic reactions further complicate the market landscape, necessitating rigorous testing and monitoring. The market also faces challenges from the increasing adoption of alternative imaging modalities that do not require contrast agents, such as ultrasound or advanced non-contrast MRI techniques. Moreover, the growing emphasis on personalized medicine demands tailored contrast agents, complicating production and increasing research and development expenditures. These factors collectively pose significant hurdles, impacting the market's growth trajectory and accessibility.

Key Players:

Bracco Imaging, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, J.B. Chemicals and Pharmaceuticals, Unijules Life Sciences, Taejoon Pharm, Jodas Expoim, Sanochemia Pharmazeutika, Spago Nanomedical, CMR Naviscan, YMBioSciences, iMax Diagnostic Imaging, Beekley Medical, Trivitron Healthcare, Magnus Life, NantPharma, Aspen Pharmacare, Ekomed

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Application
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Component
  • 2.10 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Iodinated Contrast Media
    • 4.1.2 Gadolinium-based Contrast Media
    • 4.1.3 Microbubble Contrast Media
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Oral Contrast Agents
    • 4.2.2 Intravenous Contrast Agents
    • 4.2.3 Rectal Contrast Agents
  • 4.3 Market Size & Forecast by Application (2020-2035)
    • 4.3.1 Cardiology
    • 4.3.2 Neurology
    • 4.3.3 Oncology
    • 4.3.4 Gastroenterology
    • 4.3.5 Nephrology
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Computed Tomography (CT)
    • 4.4.2 Magnetic Resonance Imaging (MRI)
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Hospitals
    • 4.5.2 Diagnostic Imaging Centers
    • 4.5.3 Ambulatory Surgical Centers
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Liquid
    • 4.6.2 Powder
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Organic
    • 4.7.2 Inorganic
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Diagnostic
    • 4.8.2 Therapeutic
  • 4.9 Market Size & Forecast by Component (2020-2035)
    • 4.9.1 Active Pharmaceutical Ingredients
    • 4.9.2 Excipients
  • 4.10 Market Size & Forecast by Equipment (2020-2035)
    • 4.10.1 CT Scanners
    • 4.10.2 MRI Machines

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Application
      • 5.2.1.4 Technology
      • 5.2.1.5 End User
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 Functionality
      • 5.2.1.9 Component
      • 5.2.1.10 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Application
      • 5.2.2.4 Technology
      • 5.2.2.5 End User
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 Functionality
      • 5.2.2.9 Component
      • 5.2.2.10 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Application
      • 5.2.3.4 Technology
      • 5.2.3.5 End User
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 Functionality
      • 5.2.3.9 Component
      • 5.2.3.10 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Application
      • 5.3.1.4 Technology
      • 5.3.1.5 End User
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 Functionality
      • 5.3.1.9 Component
      • 5.3.1.10 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Application
      • 5.3.2.4 Technology
      • 5.3.2.5 End User
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 Functionality
      • 5.3.2.9 Component
      • 5.3.2.10 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Application
      • 5.3.3.4 Technology
      • 5.3.3.5 End User
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 Functionality
      • 5.3.3.9 Component
      • 5.3.3.10 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Application
      • 5.4.1.4 Technology
      • 5.4.1.5 End User
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 Functionality
      • 5.4.1.9 Component
      • 5.4.1.10 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Application
      • 5.4.2.4 Technology
      • 5.4.2.5 End User
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 Functionality
      • 5.4.2.9 Component
      • 5.4.2.10 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Application
      • 5.4.3.4 Technology
      • 5.4.3.5 End User
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 Functionality
      • 5.4.3.9 Component
      • 5.4.3.10 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Application
      • 5.4.4.4 Technology
      • 5.4.4.5 End User
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 Functionality
      • 5.4.4.9 Component
      • 5.4.4.10 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Application
      • 5.4.5.4 Technology
      • 5.4.5.5 End User
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 Functionality
      • 5.4.5.9 Component
      • 5.4.5.10 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Application
      • 5.4.6.4 Technology
      • 5.4.6.5 End User
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 Functionality
      • 5.4.6.9 Component
      • 5.4.6.10 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Application
      • 5.4.7.4 Technology
      • 5.4.7.5 End User
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 Functionality
      • 5.4.7.9 Component
      • 5.4.7.10 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Application
      • 5.5.1.4 Technology
      • 5.5.1.5 End User
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 Functionality
      • 5.5.1.9 Component
      • 5.5.1.10 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Application
      • 5.5.2.4 Technology
      • 5.5.2.5 End User
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 Functionality
      • 5.5.2.9 Component
      • 5.5.2.10 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Application
      • 5.5.3.4 Technology
      • 5.5.3.5 End User
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 Functionality
      • 5.5.3.9 Component
      • 5.5.3.10 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Application
      • 5.5.4.4 Technology
      • 5.5.4.5 End User
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 Functionality
      • 5.5.4.9 Component
      • 5.5.4.10 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Application
      • 5.5.5.4 Technology
      • 5.5.5.5 End User
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 Functionality
      • 5.5.5.9 Component
      • 5.5.5.10 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Application
      • 5.5.6.4 Technology
      • 5.5.6.5 End User
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 Functionality
      • 5.5.6.9 Component
      • 5.5.6.10 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Application
      • 5.6.1.4 Technology
      • 5.6.1.5 End User
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 Functionality
      • 5.6.1.9 Component
      • 5.6.1.10 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Application
      • 5.6.2.4 Technology
      • 5.6.2.5 End User
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 Functionality
      • 5.6.2.9 Component
      • 5.6.2.10 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Application
      • 5.6.3.4 Technology
      • 5.6.3.5 End User
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 Functionality
      • 5.6.3.9 Component
      • 5.6.3.10 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Application
      • 5.6.4.4 Technology
      • 5.6.4.5 End User
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 Functionality
      • 5.6.4.9 Component
      • 5.6.4.10 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Application
      • 5.6.5.4 Technology
      • 5.6.5.5 End User
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 Functionality
      • 5.6.5.9 Component
      • 5.6.5.10 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bracco Imaging
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Guerbet
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Lantheus Medical Imaging
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Daiichi Sankyo
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 J.B. Chemicals and Pharmaceuticals
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Unijules Life Sciences
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Taejoon Pharm
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Jodas Expoim
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Sanochemia Pharmazeutika
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Spago Nanomedical
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 CMR Naviscan
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 YMBioSciences
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 iMax Diagnostic Imaging
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Beekley Medical
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Trivitron Healthcare
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Magnus Life
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 NantPharma
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Aspen Pharmacare
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Ekomed
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us